Table 5.
Disease | Sites | Patients | Stage 0 | Follow-up range (months) |
---|---|---|---|---|
Nononcological patients | Max | 8 | 4 | 6–29 |
Mand | 7 | 3 | ||
| ||||
Oncological patients | Max | 20 | 10 | 6–50 |
Mand | 28 | 12 |
Disease | Sites | Patients | Stage 0 | Follow-up range (months) |
---|---|---|---|---|
Nononcological patients | Max | 8 | 4 | 6–29 |
Mand | 7 | 3 | ||
| ||||
Oncological patients | Max | 20 | 10 | 6–50 |
Mand | 28 | 12 |